Related Experiment Videos

Metabolism of 1,2-dimethylhydrazine by cultured human colon

Carcinogenesis
|May 1, 1980
PubMed

Insights

Human colon explant studies reveal significant variations in 1,2-dimethylhydrazine DNA binding. Certain chemicals alter this binding, impacting colon cancer risk.

Area of Science:

  • Biochemistry
  • Toxicology
  • Gastroenterology

Background:

  • 1,2-dimethylhydrazine is a colon carcinogen in rodents.
  • Understanding its metabolism in humans is crucial for cancer research.
  • Human colon explant cultures provide a model for studying carcinogen metabolism.

Purpose of the Study:

  • To investigate the metabolism and DNA binding of 1,2-dimethylhydrazine in human colon explants.
  • To identify variations in binding levels across individuals and anatomical sites.
  • To determine the effect of exogenous chemicals on 1,2-dimethylhydrazine metabolism.

Main Methods:

  • Human colon explant cultures were used to study 1,2-dimethylhydrazine metabolism.
  • DNA binding levels were quantified, including metabolite reaction and incorporation.
  • Explants were co-incubated with 1,2-dimethylhydrazine and various exogenous chemicals.

Main Results:

  • A 100-fold variation in 1,2-dimethylhydrazine DNA binding was observed among 120 individuals.
  • The ascending and sigmoid colon showed the highest mean binding levels.
  • Exogenous chemicals like indole 3-carbinol and phenobarbital increased binding, while disulfiram and BHT decreased it.

Conclusions:

  • Individual variability in 1,2-dimethylhydrazine DNA binding is substantial.
  • Anatomical site influences binding levels within the colon.
  • Modulation of 1,2-dimethylhydrazine metabolism by exogenous chemicals offers potential targets for intervention.

Related Concept Videos